ELDISINE vindesine sulfate 5mg powder for injection vial

国家: 澳大利亚

语言: 英文

来源: Department of Health (Therapeutic Goods Administration)

有效成分:

vindesine sulfate, Quantity: 5 mg

可用日期:

Aspen Pharmacare Australia Pty Ltd

药物剂型:

Injection, powder for

组成:

Excipient Ingredients: mannitol

给药途径:

Intravenous

每包单位数:

1 vial of powder 5mg

处方类型:

(S4) Prescription Only Medicine

疗效迹象:

This product accepted for registration/listing as 'currently supplied' at the time of commencement of the Act. Indications held in ARTG paper records. (Old code) ELDISINE is indicated in the palliative treatment of the following: Acute lymphocytic leukaemia of childhood resistant to other agents. Blastic crises of chronic myeloid leukaemia in adults. Non-small cell lung cancer. It should be noted that ELDISINE is usually given in combination with other oncolytic agents.

產品總結:

Visual Identification: A white to off-white lyophilised plug; Container Type: Vial; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

授权状态:

Licence status A

授权日期:

1997-08-14